CtBP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CtBP Antibodies for research focused on understanding C-terminal binding protein (CtBP) in various cellular processes. CtBP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C-terminal binding protein functions as a transcriptional co-repressor with significant influence on gene expression, cell proliferation, and apoptosis. Research has shown that CtBP plays essential roles in developmental processes and cancer progression, making it a focal point in both basic and applied research. Understanding CtBP mechanisms can reveal potential therapeutic targets for various diseases. Investigating CtBP activity provides valuable insights into cellular regulation and disease development. Exploring CtBP pathways helps advance knowledge of transcriptional control mechanisms. Research utilizing CtBP monoclonal antibodies contributes to uncovering new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CtBP support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.